Management of cutaneous melanoma, N Engl JMed, vol.351, pp.998-1012, 2004. ,
Vaccinal cell therapy in melanoma, Bull Cancer, vol.90, pp.722-755, 2003. ,
Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects, Cancer Immunol Immunother, vol.52, pp.438-482, 2003. ,
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection, Int J Cancer, vol.93, pp.243-51, 2001. ,
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocytederived dendritic cells, JExp Med, vol.195, pp.1279-88, 2002. ,
IL-12-deficient dendritic cells, generated in the presence of prostaglandin E 2 , promote type 2 cytokine production in maturing human naive T helper cells, J Immunol, vol.159, pp.28-35, 1997. ,
Dendritic cells star in Vancouver, J Exp Med, vol.202, pp.5-10, 2005. ,
Identification of a clinical-grade maturation factor for dendritic cells, J Immunother, vol.25, pp.88-96, 2002. ,
The new melanoma staging system, Tumori, vol.87, pp.64-72, 2001. ,
Simplified method to generate large quantities of dendritic cells suitable for clinical applications, Immunol Invest, vol.29, pp.319-355, 2000. ,
Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin Chem, vol.43, pp.2424-2430, 1997. ,
Biodistributionof radiolabelled human dendritic cells injected by various routes, EurJNucl Med Mol Imaging, vol.32, pp.731-772, 2005. ,
Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat Med, vol.6, pp.707-717, 2000. ,
, Cancer Therapy: Clinical www.aacrjournals.org
, Clin Cancer Res, vol.12, issue.24, p.7388, 2006.
The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent, J Chronic Dis, vol.13, pp.346-53, 1961. ,
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate, Cancer Immunol Immunother, vol.55, pp.819-848, 2006. ,
Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE 2 : the importance of maturation cocktails, J Immunother, vol.28, pp.480-487, 2005. ,
Generation and maturation of dendritic cells for clinical application under serum-free conditions, J Immunother, vol.28, pp.599-609, 2005. ,
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy, Nat Biotechnol, vol.23, pp.1407-1420, 2005. ,
Autologous human macrophages and anti-tumour cell therapy, Res Immunol, vol.149, pp.663-71, 1998. ,
Optimizing the exogenous antigen loading of monocyte-derived dendritic cells, Int Immunol, vol.17, pp.621-656, 2005. ,
Autologous dendritic cells for treatment of advanced cancer-an update, Recent Results Cancer Res, vol.158, pp.236-284, 2001. ,
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine, Cancer Res, vol.61, pp.6451-6459, 2001. ,
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells, Int J Cancer, vol.86, pp.385-92, 2000. ,
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy, J Immunother, vol.27, pp.354-67, 2004. ,
Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8 + T-cell function in melanoma patients, J Clin Oncol, vol.21, pp.3826-3861, 2003. ,
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen, J Exp Med, vol.201, pp.249-57, 2005. ,
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J Immunol, vol.175, pp.4797-805, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482064
Determinant spreading and tumor responses after peptide-based cancer immunotherapy, Trends Immunol, vol.24, pp.58-61, 2003. ,
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur J Immunol, vol.31, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482156
Naive CD8 + T cell recruitment and proliferation are dependent on stage of dendritic cell maturation, Eur J Immunol, vol.33, pp.162-71, 2003. ,
Tolerogenic dendritic cells: cytokine modulation comes of age, Blood, vol.108, pp.1435-1475, 2006. ,
Suppressive properties of human CD4 + CD25 + regulatory T cells are dependent on CTLA-4 expression, Eur J Immunol, vol.34, pp.3485-96, 2004. ,
Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood, J Exp Med, vol.193, pp.1303-1313, 2001. ,
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines, Blood, vol.107, pp.628-664, 2006. ,
Migration of dendritic cell based cancer vaccines: in vivo veritas?, Curr Opin Immunol, vol.17, pp.170-174, 2005. ,
Regulation of dendritic cell migration to the draining lymph node: impact onT lymphocyte traffic and priming, J Exp Med, vol.198, pp.615-636, 2003. ,
Vaccination of melanoma patients with peptide-or tumor lysatepulsed dendritic cells, Nat Med, vol.4, pp.328-360, 1998. ,